Real life experience with the new lipid-lowering treatment: bempedoic acid

被引：0
|
作者：
Mujani, Nicolas Mubiayi [1 ]
Sperone, Alexandra [1 ]
Demeure, Fabian [2 ]
Descamps, Olivier [1 ]
机构：
[1] Ctr Hosp Univ HELORA, Dept Internal Med, La Louviere, Belgium
[2] CHU UCL Mt Godinne, Cardiol Dept, Namur, Belgium
来源：
ACTA CLINICA BELGICA | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
30
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [31] Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis
    Perera, Kanila
    Kam, Ning
    Ademi, Zanfina
    Liew, Danny
    Zomer, Ella
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (06) : 772 - 783
  • [32] Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials
    Shravan Venkatraman
    Saibal Das
    Madhavi Eerike
    Jerin Jose Cherian
    Bhavani Shankara Bagepally
    European Journal of Clinical Pharmacology, 2023, 79 : 1453 - 1463
  • [33] Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization
    Kadoglou, Nikolaos P. E.
    Sailer, Nikolaos
    Moumtzouoglou, Anestis
    Kapelouzou, Alkistis
    Gerasimidis, Thomas
    Liapis, Christos D.
    JOURNAL OF VASCULAR SURGERY, 2010, 51 (01) : 114 - 121
  • [34] LIPID-LOWERING AND ANTIOBESITY EFFECT OF (-)HYDROXYCITRIC ACID
    RAO, RN
    SAKARIAH, KK
    NUTRITION RESEARCH, 1988, 8 (02) : 209 - 212
  • [35] Simulation of bempedoic acid in the lipid-lowering treatment pathway using the European contemporary SANTORINI cohort of high- and very high-risk patients
    Ray, K. K.
    Catapano, A. L.
    Diamand, F.
    Wolowacz, S.
    Haq, I.
    Bilitou, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2377 - 2377
  • [36] PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
    Cainzos-Achirica, Miguel
    Martin, Seth S.
    Cornell, John E.
    Murow, Cynthia D.
    Guallar, Eliseo
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (01) : 64 - 65
  • [37] Real world effectiveness of lipid-lowering medication in Denmark
    Jensen, Camilla B.
    Hoe, Jakob Kronkvist
    Hansen, Susanne
    Olsen, Rasmus Huan
    Johansen, Tina
    Jimenez-Solem, Espen
    Petersen, Janne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 342 - 343
  • [38] Adherence to lipid-lowering treatment: the patient perspective
    Casula, Manuela
    Tragni, Elena
    Catapano, Alberico Luigi
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 805 - 814
  • [39] Medication persistence with lipid-lowering treatment in Slovenia
    Deticek, Andreja
    Kersmanc, Nina Evelina
    Mardetko, Nika
    Kos, Mitja
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (03) : 624 - 625
  • [40] Lipid-lowering treatment: Effects on endothelial dysfunction
    Rubba, P
    Mancini, M
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 348 - 353
12345